Sanofi Options Immunology Development Candidate From Recursion Collaboration
Recursion says Sanofi has exercised an option on a potential first-in-class immunology development candidate from their collaboration.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.